Influenza virus vaccine 2026 (trivalent - Singapore/Switzerland/Michigan) Injectable Suspension
RxNorm 2738136
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2738136 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: influenza virus vaccine 2026 (trivalent - Singapore/Switzerland/Michigan) Injectable Suspension.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Influenza A virus A/Singapore/GP20238/2024 (H3N2) antigen 0.03 mg/ML / influenza A virus A/Switzerland/6849/2025 (H1N1) antigen 0.03 mg/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 mg/ML Injectable Suspension
(Atom ID: 13043908)
PSNPrescribable
Prescribable Name (PSN):
Influenza virus vaccine 2026 (trivalent - Singapore/Switzerland/Michigan) Injectable Suspension
(Atom ID: 13044793)
SYPrescribable